OPUS GENETICS INC. - COMMON STOCK
1.1800
01-十一月-24 15:59:56
15 分钟延时
股票
-0.0200
-1.67%
今日范围
1.1600 - 1.2185
ISIN
N/A
来源
NASDAQ
-
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
29 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
15 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
12 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
08 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
06 9月 2022 09:00:01 条件 Nasdaq GlobeNewswire
-
12 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
08 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
03 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
07 7月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
29 6月 2022 09:00:37 条件 Nasdaq GlobeNewswire
-
08 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
19 5月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update
13 5月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
11 5月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Ocuphire Announces Upcoming Clinical Presentations at ARVO 2022 Medical Meeting and MODLive! 2022
26 4月 2022 09:00:02 条件 Nasdaq GlobeNewswire
-
19 4月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
06 4月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
29 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
24 3月 2022 08:00:01 条件 Nasdaq GlobeNewswire